About

About Aragen Life Sciences Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. We offer end-to-end integrated or standalone solutions for small and large molecules. Established in 2001, we now operate from our network of sites located globally with a team of 3700+ scientists and 475+ PhDs. Our expertise and experience have enabled over 450+ customers in advancing their research programs from discovery through commercialization. Aragen’s innovative mindset, infrastructure, flexible business models have enabled us to serve large pharma or biotech, agrochemical, animal health and performance chemical industries globally. All our facilities conform to stringent regulatory standards. Our infrastructure has a built-up area of 1.2 million square feet, housing chemistry and biology labs, AAALAC-accredited animal houses, analytical labs, formulation development labs, kilo labs, pilot plants and manufacturing facilities. Aragen has been inspected by all the leading regulatory agencies of the world, including USFDA, WHO, PMDA, EDQM and EMEA. Aragen has submitted its letter of intent to the Science Based Targets initiative (SBTi) and is part of a growing list of organizations that are committed to setting emission reduction targets in line with the Paris Agreement to limit global warming. It is also a signatory to the GRI South Asia Charter on Sustainability Imperatives, a framework that helps to realize the 17 Sustainable Development Goals (SDGs) defined by the United Nation. We are proud to be a Great Place to Work® (GPTW) certified company for the third consecutive year in 2022. This recognition confirms our High-Trust, High-Performance Culture™ and places us among ‘companies with the best culture’ to work with. For more details, visit www.aragen.com Aragen Life Sciences is a globally renowned R&D and manufacturing solutions provider to the global life sciences industries. It offers a range of solutions across the drug discovery, development and manufacturing continue to advance small and large-molecule programs. The Company operates through a global network of six sites with a team of ~5000 employees and 450+ PhDs. Its expertise and experience have enabled over 400 customers to advance their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Aragen Life Sciences is a leading full-service CRDMO offering end-to-end solutions across the drug development lifecycle. With expertise spanning both small and large molecules, Aragen supports global biopharma and biotech companies in advancing molecules from early discovery through development to commercial manufacturing. Our integrated capabilities include discovery research, process development, formulation, analytical services, and scalable manufacturing. Full-service CRDMO powered by digital and AI, Aragen is committed to accelerating innovation and delivering high-quality, timely, and cost-effective solutions.